Acorda Therapeutics
ACOR
#10103
Rank
โ‚น69.36 M
Marketcap
โ‚น55.84
Share price
0.00%
Change (1 day)
-95.58%
Change (1 year)

Revenue for Acorda Therapeutics (ACOR)

Revenue in 2024 (TTM): โ‚น9.59 Billion

According to Acorda Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น9.77 Billion. In 2023 the company made a revenue of โ‚น9.79 Billion a decrease over the revenue in the year 2022 that were of โ‚น9.81 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acorda Therapeutics from 2006 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น9.59 B-2.02%
2023 โ‚น9.79 B-0.19%
2022 โ‚น9.81 B2.13%
2021 โ‚น9.60 B-14.13%
2020 โ‚น11.18 B-18.47%
2019 โ‚น13.72 B-58.38%
2018 โ‚น32.96 B-12.24%
2017 โ‚น37.56 B6.38%
2016 โ‚น35.30 B7.85%
2015 โ‚น32.73 B28.67%
2014 โ‚น25.44 B22.42%
2013 โ‚น20.78 B24.13%
2012 โ‚น16.74 B8.31%
2011 โ‚น15.45 B80.62%
2010 โ‚น8.55 B237.38%
2009 โ‚น2.53 B10.36%
2008 โ‚น2.29 B48.35%
2007 โ‚น1.54 B27.92%
2006 โ‚น1.21 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น50.88 B 420.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น232.55 B 2,280.01%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.24 B-97.52%๐Ÿ‡ฉ๐Ÿ‡ช Germany
โ‚น127.14 B 1,201.18%๐Ÿ‡บ๐Ÿ‡ธ USA